103 related articles for article (PubMed ID: 30735462)
61. Society of behavioral medicine supports increasing HPV vaccination uptake: an urgent opportunity for cancer prevention.
Peterson CE; Dykens JA; Brewer NT; Buscemi J; Watson K; Comer-Hagans D; Ramamonjiarivelo Z; Fitzgibbon M
Transl Behav Med; 2016 Dec; 6(4):672-675. PubMed ID: 27718061
[TBL] [Abstract][Full Text] [Related]
62. What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions.
Perkins RB; Clark JA
Womens Health Issues; 2012; 22(4):e379-86. PubMed ID: 22609253
[TBL] [Abstract][Full Text] [Related]
63. Acceptance and compliance with postpartum human papillomavirus vaccination.
Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
[TBL] [Abstract][Full Text] [Related]
64. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study.
Perkins RB; Clark JA; Apte G; Vercruysse JL; Sumner JJ; Wall-Haas CL; Rosenquist AW; Pierre-Joseph N
Pediatrics; 2014 Sep; 134(3):e666-74. PubMed ID: 25136036
[TBL] [Abstract][Full Text] [Related]
65. Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine.
Chang RS; Shing JZ; Erves JC; Du L; Koyama T; Deppen S; Rentuza AB; McAfee C; Stroebel C; Cates J; Harnack L; Andrews D; Bramblett R; Hull PC
BMC Med Inform Decis Mak; 2022 Dec; 22(1):339. PubMed ID: 36550466
[TBL] [Abstract][Full Text] [Related]
66. Attitudes surrounding implementation of the HPV vaccine for males among primary care providers serving large minority populations.
Aragones A; Bruno D; Gany F
J Health Care Poor Underserved; 2013 May; 24(2):768-76. PubMed ID: 23728043
[TBL] [Abstract][Full Text] [Related]
67. Availability of the HPV Vaccine in Regional Pharmacies and Provider Perceptions Regarding HPV Vaccination in the Pharmacy Setting.
Maples JM; Zite NB; Oyedeji O; Chamberlin SM; Mastronardi AM; Gregory S; Gatwood JD; Hohmeier KC; Booker ME; Perry JD; Moss HK; Kilgore LC
Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334983
[TBL] [Abstract][Full Text] [Related]
68. Treatment approaches and costs associated with diabetes clinical metrics as measured by Healthcare Effectiveness Data and Information Set (HEDIS).
Alkhaddo J; Rung JM; Khowaja A; Yin Y; Richards SB; Drury-Gworek C; Afreen S; Rossi C; Manzi S
BMC Health Serv Res; 2024 Mar; 24(1):375. PubMed ID: 38532406
[TBL] [Abstract][Full Text] [Related]
69. Human Papillomavirus Vaccination Rates in Patients Living With Human Immunodeficiency Virus (HIV).
Boivin N; Desai S
Cureus; 2024 Apr; 16(4):e57558. PubMed ID: 38707117
[TBL] [Abstract][Full Text] [Related]
70. Recovery of measles-containing and HPV vaccine ordering post-COVID-19 pandemic: Trends by public vs. private funding source, urbanicity, and state - United States, January 2018 - December 2022.
Kang Y; Meador S; Black CL; Vogt T
Prev Med; 2024 May; 182():107936. PubMed ID: 38493896
[TBL] [Abstract][Full Text] [Related]
71. Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery.
Gountas I; Favre-Bulle A; Saxena K; Wilcock J; Collings H; Salomonsson S; Skroumpelos A; Sabale U
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851136
[TBL] [Abstract][Full Text] [Related]
72. Measuring the overall performance of mental healthcare providers.
Aragón MJ; Gravelle H; Castelli A; Goddard M; Gutacker N; Mason A; Rowen D; Mannion R; Jacobs R
Soc Sci Med; 2024 Mar; 344():116582. PubMed ID: 38394864
[TBL] [Abstract][Full Text] [Related]
73. Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics.
Barnard JG; Marsh R; Anderson-Mellies A; Williams JL; Fisher MP; Cockburn MG; Dempsey AF; Cataldi JR
Vaccine; 2022 Aug; 40(33):4835-4844. PubMed ID: 35792022
[TBL] [Abstract][Full Text] [Related]
74. Human papilloma virus vaccination and cervical cancer screening coverage in managed care plans - United States, 2018.
Richards TB; Lindley MC; Byron SC; Saraiya M
Prev Med; 2022 Jun; 159():107019. PubMed ID: 35283162
[TBL] [Abstract][Full Text] [Related]
75. There's Much Yet to be Done: Diverse Perspectives on HPV Vaccination.
Zimet GD; Osazuwa-Peters N
Hum Vaccin Immunother; 2019; 15(7-8):1459-1464. PubMed ID: 31365327
[No Abstract] [Full Text] [Related]
76. Provider-level rates of HEDIS-consistent HPV vaccination in a regional health plan.
Panozzo CA; Gilkey MB; Kornides ML; Wharam JF
Hum Vaccin Immunother; 2019; 15(7-8):1708-1714. PubMed ID: 30735462
[No Abstract] [Full Text] [Related]
77. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
[TBL] [Abstract][Full Text] [Related]
78. Supporting Human Papillomavirus Vaccination in Adolescents: Perspectives From Commercial and Medicaid Health Plans.
Ng JH; Sobel K; Roth L; Byron SC; Lindley MC; Stokley S
J Public Health Manag Pract; 2017; 23(3):283-290. PubMed ID: 27798527
[TBL] [Abstract][Full Text] [Related]
79. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey.
Walling EB; Dodd S; Bobenhouse N; Reis EC; Sterkel R; Garbutt J
Am J Prev Med; 2019 Jan; 56(1):74-83. PubMed ID: 30573149
[TBL] [Abstract][Full Text] [Related]
80. Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.
Rieck T; Feig M; Deleré Y; Wichmann O
Vaccine; 2014 Sep; 32(43):5564-9. PubMed ID: 25131739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
